X-15331315-T-C

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 2P and 7B. PM5BP4_ModerateBP6BS2

The NM_002641.4(PIGA):​c.616A>G​(p.Ile206Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000664 in 1,204,690 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 2 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. I206F) has been classified as Pathogenic.

Frequency

Genomes: 𝑓 0.000027 ( 0 hom., 1 hem., cov: 23)
Exomes 𝑓: 0.0000046 ( 0 hom. 1 hem. )

Consequence

PIGA
NM_002641.4 missense

Scores

1
9
7

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:1

Conservation

PhyloP100: 7.58

Publications

6 publications found
Variant links:
Genes affected
PIGA (HGNC:8957): (phosphatidylinositol glycan anchor biosynthesis class A) This gene encodes a protein required for synthesis of N-acetylglucosaminyl phosphatidylinositol (GlcNAc-PI), the first intermediate in the biosynthetic pathway of GPI anchor. The GPI anchor is a glycolipid found on many blood cells and which serves to anchor proteins to the cell surface. Paroxysmal nocturnal hemoglobinuria, an acquired hematologic disorder, has been shown to result from mutations in this gene. Alternate splice variants have been characterized. A related pseudogene is located on chromosome 12. [provided by RefSeq, Jun 2010]
PIGA Gene-Disease associations (from GenCC):
  • multiple congenital anomalies-hypotonia-seizures syndrome 2
    Inheritance: XL Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Illumina, Labcorp Genetics (formerly Invitae), Orphanet
  • infantile spasms
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • malignant migrating partial seizures of infancy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • ferro-cerebro-cutaneous syndrome
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • paroxysmal nocturnal hemoglobinuria
    Inheritance: Unknown Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

PM5
Other missense variant is known to change same aminoacid residue: Variant chrX-15331315-T-A is described in ClinVar as Pathogenic. ClinVar VariationId is 132817.Status of the report is no_assertion_criteria_provided, 0 stars.
BP4
Computational evidence support a benign effect (MetaRNN=0.24032837).
BP6
Variant X-15331315-T-C is Benign according to our data. Variant chrX-15331315-T-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 424453.
BS2
High AC in GnomAdExome4 at 5 Unknown,XL,AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PIGANM_002641.4 linkc.616A>G p.Ile206Val missense_variant Exon 2 of 6 ENST00000333590.6 NP_002632.1 P37287-1A0A2K4ZA02

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PIGAENST00000333590.6 linkc.616A>G p.Ile206Val missense_variant Exon 2 of 6 1 NM_002641.4 ENSP00000369820.3 P37287-1

Frequencies

GnomAD3 genomes
AF:
0.0000267
AC:
3
AN:
112258
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000284
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000164
AC:
3
AN:
183476
AF XY:
0.0000294
show subpopulations
Gnomad AFR exome
AF:
0.000152
Gnomad AMR exome
AF:
0.0000365
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000458
AC:
5
AN:
1092378
Hom.:
0
Cov.:
28
AF XY:
0.00000279
AC XY:
1
AN XY:
357884
show subpopulations
African (AFR)
AF:
0.000114
AC:
3
AN:
26274
American (AMR)
AF:
0.00
AC:
0
AN:
35203
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19361
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30188
South Asian (SAS)
AF:
0.00
AC:
0
AN:
54031
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40533
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4119
European-Non Finnish (NFE)
AF:
0.00000120
AC:
1
AN:
836769
Other (OTH)
AF:
0.0000218
AC:
1
AN:
45900
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.463
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000267
AC:
3
AN:
112312
Hom.:
0
Cov.:
23
AF XY:
0.0000290
AC XY:
1
AN XY:
34462
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30889
American (AMR)
AF:
0.000283
AC:
3
AN:
10595
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2650
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3605
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2709
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6150
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
218
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
53276
Other (OTH)
AF:
0.00
AC:
0
AN:
1533
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.425
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000151
ExAC
AF:
0.0000165
AC:
2

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
Sep 13, 2016
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The p.I206V variant (also known as c.616A>G), located in coding exon 1 of the PIGA gene, results from an A to G substitution at nucleotide position 616. The isoleucine at codon 206 is replaced by valine, an amino acid with highly similar properties. Another variant at the same amino acid position (p.I206F) has been reported in a patient diagnosed with West syndrome with hypomyelination (Kato M et al. Neurology, 2014 May;82:1587-96). The p.I206V variant was previously reported in the SNPDatabase as rs201119959. Based on data from the 1000 Genomes Project, the G allele has an overall frequency of approximately 0% (0/503) total male alleles studied. In the NHLBI Exome Sequencing Project (ESP), this variant was not observed in 6503 samples with coverage at this position. This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this variant remains unclear. -

not provided Uncertain:1
Mar 29, 2017
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

A variant of uncertain significance has been identified in the PIGA gene. The I206V variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. A different missense substitution at the same residue (I206F) has been previously reported as a maternally inherited variant in a male with West syndrome (Kato et al. 2014). The I206V variant is observed in 1/9319 (0.01%) alleles from individuals of Latino background, (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). This substitution occurs at a position that is conserved across species. However, the I206V variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. In silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. Therefore, based on the currently available information, it is unclear whether this variant is a pathogenic variant or a rare benign variant. -

Multiple congenital anomalies-hypotonia-seizures syndrome 2 Benign:1
Nov 03, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.44
BayesDel_addAF
Benign
-0.071
T
BayesDel_noAF
Uncertain
-0.080
CADD
Benign
23
DANN
Uncertain
1.0
DEOGEN2
Benign
0.21
T;T
FATHMM_MKL
Uncertain
0.94
D
LIST_S2
Pathogenic
0.99
.;D
M_CAP
Uncertain
0.12
D
MetaRNN
Benign
0.24
T;T
MetaSVM
Benign
-0.43
T
MutationAssessor
Uncertain
2.1
M;M
PhyloP100
7.6
PrimateAI
Uncertain
0.78
T
PROVEAN
Benign
-0.82
N;N
REVEL
Uncertain
0.48
Sift
Benign
0.047
D;T
Sift4G
Uncertain
0.037
D;D
Polyphen
0.66
P;P
Vest4
0.63
MutPred
0.52
Loss of sheet (P = 0.0817);Loss of sheet (P = 0.0817);
MVP
0.88
MPC
1.2
ClinPred
0.20
T
GERP RS
4.4
Varity_R
0.39
gMVP
0.92
Mutation Taster
=91/9
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs201119959; hg19: chrX-15349437; API